compare glp-1 Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Comparisons of GLP-1 RAs.8,49,64-69,70-73 |
Description
Once you begin compounded semaglutide or another GLP-1, monitoring looks different for lupus patients than for the general population
The most common side effects of this class of medication include nausea, vomiting, diarrhea, and loss of appetite
however, more adverse effects (e.g., gastrointestinal) were recorded [126]
This is especially true if we continue to sit after eating a meal
